In silico analysis identifies CRISP3 as a potential peripheral blood biomarker for multiple myeloma: From data modeling to validation with RT-PCR.
about
In silico analysis identifies CRISP3 as a potential peripheral blood biomarker for multiple myeloma: From data modeling to validation with RT-PCR.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
In silico analysis identifies ...... ing to validation with RT-PCR.
@en
In silico analysis identifies ...... ing to validation with RT-PCR.
@nl
type
label
In silico analysis identifies ...... ing to validation with RT-PCR.
@en
In silico analysis identifies ...... ing to validation with RT-PCR.
@nl
prefLabel
In silico analysis identifies ...... ing to validation with RT-PCR.
@en
In silico analysis identifies ...... ing to validation with RT-PCR.
@nl
P2093
P2860
P356
P1433
P1476
In silico analysis identifies ...... ing to validation with RT-PCR.
@en
P2093
P2860
P304
P356
10.3892/OL.2018.7969
P577
2018-02-06T00:00:00Z